Clinuvel Pharmaceuticals Quote - CUV

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

13.10

Bid

13.10

Offer

13.20

Volume

128,886

13.10 Day's Range 13.79

12.96 52 Week Range 18.20

Market Cap

656.359M

Previous Close

13.395

Open

13.49

Last Trade

13.16

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

87,327

Shares Outstanding

50,103,765

Dividend Yield

PE Ratio

18.42

Earnings Per Share (EPS)

0.71

Revenue

88.74M

Net Profit

35.64M

Sector

Medicinal Chems,botanicl Pds

Industry

Drugs-health R&d/testing Labs

Website

www.clinuvel.com

Headquarters

Melbourne, Victoria, Aus

Founded

2000

Clinuvel Pharmaceuticals Limited is listed in the Medicinal Chems,botanicl Pds sector of the Australian Stock Exchange with ticker CUV. The last closing price for Clinuvel Pharmaceuticals was AUD13.40. Over the last year, Clinuvel Pharmaceuticals shares have traded in a share price range of AUD 12.96 to AUD 18.20.

Clinuvel Pharmaceuticals currently has 50,103,765 shares in issue. The market capitalisation of Clinuvel Pharmaceuticals is AUD671.14 million. Clinuvel Pharmaceuticals has a price to earnings ratio (PE ratio) of 18.42.

Europe Approves Novel Australian Drug Developed for Rare Sun Disease

The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the European Medicines Agency (EMA...

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study Primary endpoint shows a strong statistical trend in pain-free exposure following the treatment of the 'orphan...

Clinuvel Files European Marketing Authorisation Application for SCENESSE® (afamelanotide)

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class...

Clinuvel announces positive results of first Phase II US study of SCENESSE® in orphan disease erythropoietic protoporphyria ...

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY), a global biopharmaceutical company with unique expertise on the interaction of light and human skin...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.53	-3.88848129127	13.63	14.05	13.01	84847	13.54061315	DE
4	-0.7	-5.07246376812	13.8	14.86	13.01	77059	13.89197073	DE
12	-0.45	-3.32103321033	13.55	15.99	13.01	87327	14.39827824	DE
26	-2.36	-15.2652005175	15.46	17.71	13.01	80841	14.68274412	DE
52	-3.64	-21.7443249701	16.74	18.2	12.96	92628	14.99534736	DE
156	-18.41	-58.4258965408	31.51	31.74	12.96	100495	18.2326125	DE
260	-16.86	-56.2750333778	29.96	44.67	12.92	123867	21.94814362	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HIQOHitIQ Limited	AUD 0.022 (633.33%)	25k
ARDOArgent Minerals Ltd	AUD 0.003 (200.00%)	18.41M
IFGInFocus Group Holdings Ltd	AUD 0.038 (153.33%)	61.11M
ADNOCAndromeda Metals Limited	AUD 0.002 (100.00%)	5M
FNRFar Northern Resources Ltd	AUD 0.18 (71.43%)	142.69k
OECROrbital Corporation Limited	AUD 0.001 (-98.48%)	9
ADXOADX Energy Limited	AUD 0.011 (-63.33%)	875k
CDECodeifai Ltd	AUD 0.001 (-50.00%)	82.68M
CRIOCritica Ltd	AUD 0.001 (-50.00%)	5M
AGEOCAlligator Energy Limited	AUD 0.01 (-28.57%)	36k
SYASayona Mining Limited	AUD 0.034 (-10.53%)	96.47M
CDECodeifai Ltd	AUD 0.001 (-50.00%)	82.68M
88E88 Energy Limited	AUD 0.002 (33.33%)	79.47M
PENPeninsula Energy Ltd	AUD 0.0545 (-3.54%)	72.33M
LPDLepidico Ltd	AUD 0.002 (0.00%)	65.86M